Macrogen Corp.
Macrogen Corp., launched in late 2012, offers diagnostic testing for genetic diseases through clinical whole-exome sequencing and targeted sequencing, and provides a "total genomic solution" for the clinical and research area. The company will expand its services to include DNA chip-based neo-genome scanning and cancer diagnostic panels, as well as transcriptome sequencing.